Using Nanotechnology Structured Water to Control Blood Glucose in Type 2 Diabetic Patients.

NCT ID: NCT04082351

Last Updated: 2019-09-10

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 387 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2016-07-03
• Study Completion Date: 2018-02-16

Brief Summary

Type 2 DM is due to insulin resistance or low insulin secretion or sometimes a combination of both. Nanotechnology structured water is a type of water that is produced using energy field modulators to change the biological, chemical, and physical properties of water molecules and improve the bioavailability of this nano-water. Objective: To find out the effect of drinking nanotechnology structured water (Magnalife®) on the blood glucose levels in patients with type 2 diabetes mellitus.

Detailed Description

This is a blind randomized control trial, according to CONSORT guidelines for randomization, "Participants were randomly assigned following simple randomization procedures (computerized random numbers) to 1 of 2 treatment groups.", that included 387 patients with Type 2 diabetes mellitus in Diabetes Care Center, Sulaymaniyah, Kurdistan region from July 2016 till February 2018. A total of 387 patients with type 2 diabetes who were patients in this center and agreed to participate in this clinical trial were included in this study.

In group A, patients were given nanotechnology structured water Magnalife® and in group B they were given ordinary bottled drinking water as a control . The bottles were unlabeled so that the patients did not know which water they were drinking. Then they were asked to eat their usual food and to drink their usual drinks, also they could drink water ad libitum after drinking the daily doses, and to have the same physical activities that they used to do in their usual daily life. They were instructed to take their medications as usual, and were told to come to test their blood sugar level at the end of the third month to get the HbA1c tested at the end of the three months of drinking the water.

Conditions

Type2 Diabetes

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

Magnalife

the group of patients receiving the nanotechnology structured water

Group Type: ACTIVE_COMPARATOR

Nanotechnology structured water ( Magnalife)

Intervention Type: DIETARY_SUPPLEMENT

Nanotechnology structured water ( Magnalife), is given as dietary supplement to the patients to drink it according to their weight .

Ordinary water

the group of patients receiving ordinary water

Group Type: PLACEBO_COMPARATOR

ordinary water

Intervention Type: DIETARY_SUPPLEMENT

Ordinary bottled water

Interventions

Nanotechnology structured water ( Magnalife)

Nanotechnology structured water ( Magnalife), is given as dietary supplement to the patients to drink it according to their weight .

Intervention Type: DIETARY_SUPPLEMENT

ordinary water

Ordinary bottled water

Intervention Type: DIETARY_SUPPLEMENT

Other Intervention Names

Magnalife; Bottled drinking water

Eligibility Criteria

Inclusion Criteria

• Type 2 diabetic patients

Exclusion Criteria

• Malignancy
• Steroids
• Immunotherapy
• Chemotherapy
• Radiotherapy
• Chronic infections
• Drugs that antagonize or synergies insulin effects

• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

ALI KAMAL M. SAMI

OTHER

Sponsor Role: lead

Responsible Party

ALI KAMAL M. SAMI

doctor, lecturer

Responsibility Role: SPONSOR_INVESTIGATOR

Principal Investigators

Ali K M.Sami, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

College of Medicine, University of Sulaimani

References

Sami AKM, Amin KH, Kurmanji MT. The Novel Use of Nanotechnology Structured Water Magnalife to Control Blood Glucose Level in Type 2 Diabetic Patients. Diabetes. 2018;67(Supplement 1):1155.

Reference Type: RESULT

Other Identifiers

USulaimani

Identifier Type: -

Identifier Source: org_study_id